SABR波动模型
医学
离格
医学物理学
放射治疗
立体定向放射治疗
放射外科
放射科
重症监护医学
随机波动
波动性(金融)
金融经济学
经济
作者
G.G. Hanna,Louise Murray,Rushil Patel,Suneil Jain,K. Aitken,K. Franks,N. van As,A. Tree,Paul Hatfield,Stephen Harrow,Fiona McDonald,Merina Ahmed,Frank Saran,G. Webster,Vincent Khoo,David Landau,David Eaton,Maria A. Hawkins
标识
DOI:10.1016/j.clon.2017.09.007
摘要
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ at risk dose constraints. Values from existing but older reviews were updated using data from current studies. It is hoped that this unified approach will facilitate standardised implementation of SABR across the UK and will allow meaningful toxicity comparisons between SABR studies and internationally.
科研通智能强力驱动
Strongly Powered by AbleSci AI